The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

The electric Maruti Suzuki e Vitara SUV is the production-spec version of the Maruti Suzuki EVX concept we saw at Auto Expo 2023. And while this may not be the first time that Suzuki has shown off ...

Let us take a look at the details here. The electric SUV comes with a 66.4 kWh battery pack which is good for an MIDC-certified range of 531 km on a single charge. The electric motor mounted on the ...

The e Vitara made its first public appearance in Milan, Italy in 2024 and is based on Maruti’s eVX concept, unveiled at the Auto Expo 2023. It’s the first born-electric model (specifically designed ...

Based on a skateboard platform (codename: 40PL) co-developed with Toyota, the e Vitara for India will have 49kWh and 61kWh battery packs, which use LFP (Lithium Iron-phosphate) ‘blade’ cells ...

Maruti Suzuki e Vitara, the leading Indian carmaker’s debutante electric vehicle for the country, has been unveiled for India. The e Vitara made its global debut in 2024 in Milan, Italy. Interestingly ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine being developed as a treatment of advanced melanoma (skin cancer). Dosing has been completed according to trial ...